Home
>
National Drug Code (NDC)
>
Methotrexate
Methotrexate - 0555-0572-02 - (Methotrexate)
Drug Information of Methotrexate
| Product NDC: | 0555-0572 |
| Proprietary Name: | Methotrexate |
| Non Proprietary Name: | Methotrexate |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Methotrexate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methotrexate
| Product NDC: | 0555-0572 |
| Labeler Name: | Barr Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA081099 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19901101 |
Package Information of Methotrexate
| Package NDC: | 0555-0572-02 |
| Package Description: | 100 TABLET in 1 BOTTLE (0555-0572-02) |
NDC Information of Methotrexate
| NDC Code | 0555-0572-02 |
| Proprietary Name | Methotrexate |
| Package Description | 100 TABLET in 1 BOTTLE (0555-0572-02) |
| Product NDC | 0555-0572 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methotrexate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19901101 |
| Marketing Category Name | ANDA |
| Labeler Name | Barr Laboratories Inc. |
| Substance Name | METHOTREXATE SODIUM |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
